ArticleJournal of clinical microbiology2011

Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency.

Erik Munson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.